<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
MLTX
MoonLake Immunotherapeutics
$
()


  • MoonLake Immunotherapeutics enters three-year partnership with Komodo Health

    4/10/2024 - 07:02am
  • Estee Lauder upgraded, Petco downgraded: Wall Street's top analyst calls

    4/2/2024 - 09:53am
  • MoonLake Immunotherapeutics initiated with neutral view at Goldman Sachs, here's why

    4/2/2024 - 04:54am
  • Ascendis, MoonLake Immunotherapeutics removed from Best Ideas List at Wedbush

    3/21/2024 - 08:33am
  • MoonLake price target raised to $100 from $75 at H.C. Wainwright

    3/11/2024 - 06:16am
  • MoonLake announces improvements with Nanobody sonelokimab over 24 weeks in PsA

    3/10/2024 - 16:06pm
  • MoonLake Immunotherapeutics price target raised by $3 at Guggenheim, here's why

    3/1/2024 - 08:14am
  • MoonLake Immunotherapeutics reports Q4 EPS (12c), consensus (23c)

    2/29/2024 - 08:02am
  • MoonLake announces feedback from FDA, EMA on path for sonelokimab program

    2/26/2024 - 08:22am
  • Short Report: Bears boost WW exposure ahead of earnings after marketing debacle

    2/24/2024 - 20:34pm
  • Wolfe starts MoonLake at Outperform, sees Q1 outperformance

    2/14/2024 - 19:19pm
  • MoonLake Immunotherapeutics initiated with bullish view at Wolfe Research

    2/14/2024 - 16:18pm
  • Largest borrow rate increases among liquid names

    1/29/2024 - 08:45am
  • Oppenheimer, Wedbush say buy these biotech stocks for 2024

    12/14/2023 - 13:31pm
  • MoonLake Immunotherapeutics initiated with bullish view at Citi, here's why

    12/8/2023 - 05:06am
dynamic_feed Breaking News